Developing a computable phenotype for glioblastoma
Sandra C. Yan(University of Florida), Ashley Ghiaseddin(University of Florida), Jiang Bian(Regenstrief Institute), Tianchen Lyu(University of Florida Health), Kaitlyn Melnick(University of Florida), Han Wang(University of Florida), Megan Still(University of Florida), Xing He(University of Florida Health), Duane A. Mitchell(University of Florida), Yi Guo(Shanghai Jiao Tong University), Elizabeth Shenkman(University of Florida)
Cited by 2
Related Papers
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
|Proceedings of the National Academy of Sciences|2019|330
Algorithmic fairness in computational medicine
|EBioMedicine|2022|143
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
|Current Treatment Options in Oncology|2020|101
Enhanced recovery after surgery (ERAS) for open transforaminal lumbar interbody fusion: a retrospective propensity-matched cohort study
|The Spine Journal|2021|51
Contemporary RNA Therapeutics for Glioblastoma
|NeuroMolecular Medicine|2021|45